The Effects of Lovastatin in Hyperlipidemic Patients With the Nephrotic Syndrome
- 1 January 1990
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 15 (1) , 8-15
- https://doi.org/10.1016/s0272-6386(12)80586-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolismKidney International, 1988
- Treatment of hyperlipidemia reduces glomerular injury in obese Zucker ratsKidney International, 1988
- Effect of Probucol on Hyperlipidemia in Patients with Nephrotic SyndromeNephron, 1987
- Serum and urinary high density lipoproteins in glomerular disease with proteinuriaKidney International, 1986
- Lipoprotein distribution and composition in the human nephrotic syndromAtherosclerosis, 1985
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- DOES THE NEPHROTIC SYNDROME INCREASE THE RISK OF CARDIOVASCULAR DISEASE?The Lancet, 1979
- COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIAThe Lancet, 1972
- ISCHIEMIC HEART-DISEASE AS A COMPLICATION OF NEPHROTIC SYNDROMEThe Lancet, 1969